ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 3.39349009784536e-005 0.62265124
NSC 329691 HM-4 4.5458043774469e-005 0.1399407
NSC 665534 5-Quinolinesulfonic acid, 7,7'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)iminocarbonyl]]bis[8-hydroxy-, tetrasodium salt 4.91939766674006e-005 0.57559648
NSC 737518 Indenoisoquinoline derivative 4.91939766674006e-005 0.7714948
NSC 757098 Melphalan (USAN) 4.91939766674006e-005 0.8054545
NSC 143147 Urea, 1,1'-(methylenedi-4,1-cyclohexylene)bis[3-(2-chloroethyl)-3-nitroso- (8CI) 5.30973832161747e-005 0.53983683
NSC 610457 Camptothecin Derivative 5.30973832161747e-005 0.77904456
NSC 700363 Liposomal Annamycin 8.12128078052024e-006 0.79165626
Total:99  Current:99    [First] [Prev] [Next] [Last]